期刊文献+

应用SELDI-TOF-MS技术初步建立子宫内膜异位症诊断模型 被引量:2

Establishment of Diagnostic Pattern for Endometriosis Using SELDI-TOF-MS
下载PDF
导出
摘要 目的:分析子宫内膜异位症(EMs)患者血清差异蛋白谱,初步建立EMs的诊断模型。方法:采用表面增强激光解析离子化飞行时间质谱(SELDI-TOF-MS)技术,用弱阳离子交换芯片(WCX2)和分析软件对79例EMs(EMs组)及72例非EMs妇女(对照组)血清样品进行检测,在不同的月经周期中分别筛选差异蛋白,建立诊断模型并进行盲法验证。结果:在质荷比(m/z)2000-30000的范围内,得到16个有统计学差异(P<0.01)的差异蛋白,进一步按月经周期分期分析,增生期和分泌期分别得到3个和6个有统计学差异的蛋白峰。增生期所建的诊断模型敏感性和特异性分别为94.3%和97.1%。盲筛结果敏感性为90.7%,特异性为93.0%,阳性预测值为92.9%,阴性预测值为90.9%。结论:利用增生期血清样品建立的诊断模型敏感性和特异性高,对EMs临床诊断和发病机理的理解具有重要意义。 Objective: To analyze differential proteins in serum of patients with and without endomvtriosis (EMs) and establish a pattern for diagnosis of endometriosis. Methods: Differential proteins of serum samples between endometriosis group(79 samples) and control group (72 samples) were detected using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), weak cation exchanger (WCX2) protein chip and Biomarker Wizard software, then diagnostic models were established in different menstrual cycle. Results: At the m/z value ranging from 2 000 to 30 000, 16 different protein fmgcrprints which were of statistical significance (P〈0.01) were detected without considering the menstrual cycle. Between the two groups in proliferative phase, 3 proteins had significant difference, 6 proteins had significant difference between samples in secretory phase. The sensitivity and specificity of the model of proliferative phase were 94.3 % and 97.1%, respectively. The blind test generated a sensitivity of 90.7%, specificity of 93.0%, positive and negative predictive value were 92.9% and 90.9%, respectively. Conclusion: The diagnostic model established according to the differential protein fingerprints in proliferative phase is the most valuable. The results of this study had a significance for the diagnosis as well as understanding of endometriosis.
出处 《生殖与避孕》 CAS CSCD 北大核心 2008年第3期168-173,共6页 Reproduction and Contraception
基金 上海市医学重点学科建设项目(05III016)
关键词 子宫内膜异位症(EMs) 表面增强激光解析离子化飞行时间质谱(SELDI—TOF-Ms) 质谱 蛋白芯片 蛋白质组 endometriosis(EMs) surface-enhanced laser desorption/ionization time-of-flight mass spectrometry(SELDI-TOF-MS) mass spectra protein chip protein
  • 相关文献

参考文献11

  • 1Kafali H, Artuc H, Demir N. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report. Eur Obstet Gynecol Reprod Biol, 2004, 116(1): 85-8. 被引量:1
  • 2王克夷.糖蛋白的糖形[J].生命的化学,1996,16(5):6-8. 被引量:10
  • 3Zhang H, Kong BH, Qu X, et al. Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol Oncol, 2006, 102(1): 61-6. 被引量:1
  • 4吕雅洁,李力,俞丽丽,许洋.妊娠期高血压疾病患者特异性血清标志物筛查的初步探讨[J].中华妇产科杂志,2005,40(5):306-308. 被引量:10
  • 5Zhao S, Qiao J. Discovery of distinct protein profiles specific for PCOS with and without IR by SELDI mass spectrometry. Fertil Steril, 2005, 84(S1): S 147-8. 被引量:1
  • 6Skytt A, Thysell E, Stattin P, et al. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. Int J Cancer, 2007, 121 (3): 615-20. 被引量:1
  • 7Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res, 2004, 10(3): 860-8. 被引量:1
  • 8Aydin A, Ioannis M, Anastasia G, et al. Increased pregnancyassociated plasma protein-A (PPAP-A) concentration in peritoneal fluid of women with endometriosis. AM J Report lmmunol, 2003, 49(2): 70-4. 被引量:1
  • 9Atia AH, Masaki M, Fujita Jun, et al. Expression of coldinducible RNA-binding protein in the normal endometrium, edometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Pathol, 2003, 22(3): 240-7. 被引量:1
  • 10Zagorianakou N, Ioachim E, Mitselou A, et al. Giycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steoid receptor status and proliferative indices (PCNA,MEB1). Eur J Gynaecol Oncol, 2003, 24(6): 500-4. 被引量:1

二级参考文献9

  • 1Stierum R, Gaspari M, Dommels Y, et al. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta, 2003,1650:73-91. 被引量:1
  • 2Adam PJ, Boyd R, Tyson KL, et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem, 2003,278:6482-6489. 被引量:1
  • 3Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet, 2003,362:433-439. 被引量:1
  • 4Srinivas PR, Verma M, Zhao Y, et al. Proteomics for cancer biomarker discovery. Clin Chem, 2002,48 :1160-1169. 被引量:1
  • 5Poland J, Schadendorf D, Lage H, et al. Study of therapy resistance in cancer cells with functional proteome analysis. Clin Chem Lab Med, 2002, 40:221-234. 被引量:1
  • 6Colburn WA. Biomarkers in drug discovery and development: from target identification through drug marketing. J Clin Pharmacol, 2003, 43: 329-341. 被引量:1
  • 7Ye B, Cramer DW, Skates SJ, et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res, 2003,9:2904-2911. 被引量:1
  • 8Batorfi J, Ye B, Mok SC, et al. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol, 2003,88:424-428. 被引量:1
  • 9Vuadens F, Benay C, Crettaz D, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics, 2003,3:1521-1525. 被引量:1

共引文献18

同被引文献14

  • 1王娜,董方霆,张学敏,李爱玲,王杰,王红霞,李萍,吴胜明,杨晓虹.水热法制备质谱专用提取多肽的金属螯合纳米磁珠[J].化学学报,2007,65(4):344-348. 被引量:5
  • 2Carr SA, Celis JE. Biomarkers and clinical proteomics[J]. Mol Cell Proteomics, 2006, 5(10): 17-9. 被引量:1
  • 3Cheng AJ, Chen LC, Chien KY, et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology[ J ]. Clin Chem, 2005, 51 (12): 2236-44. 被引量:1
  • 4Wulfkuhle JD, Liotta LA, Petricoin EF, Proteomic applications for the early detection of cancer [J]. Nat Rev Cancer, 2003, 3 (4): 267-75. 被引量:1
  • 5Eleftherios P. Diamandis mass spectrometry as a diagnostic and a cancer biomarker discovery tool [J]. Mol Cell Proteomics, 2004, 3 (4): 367-78. 被引量:1
  • 6Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer [J ]. Lancet, 2002, 359 (9306): 572-5. 被引量:1
  • 7Campa M J, Wang MZ, Howard B, et al. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin A as potential molecular targets in non-small cell lung cancer [J]. Cancer Res, 2003, 63(7): 1652-6. 被引量:1
  • 8Liu H, Lang J, Zhou Q, et al. Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-fight mass spectrometry [J]. Fertil Steril, 2007, 87(4): 988-90. 被引量:1
  • 9子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015,50(3):161-169. 被引量:1113
  • 10韩玉斌.重度子宫内膜异位症腹腔镜手术一例[J].中华妇产科杂志,2020,55(6). 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部